Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Gay

Showing results (21-30 of 174) with videos related to

Pageof 18
Sort By:
Cancers|December 19, 2019
Pursuing a Curative Approach in Multiple Myeloma: A Review of New Therapeutic StrategiesMattia D'Agostino, Luca Bertamini, Stefania Oliva, et al.
Oncotarget|September 27, 2017
Emerging drugs and combinations to treat multiple myelomaAlessandra Larocca, Roberto Mina, Francesca Gay, et al.
Expert Opinion on Investigational Drugs|June 7, 2014
Current Phase II investigational proteasome inhibitors for the treatment of multiple myelomaSara Bringhen, Francesca Gay, Francesca Donato, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 19, 2021
When and How to Treat Relapsed Multiple MyelomaNitya Nathwani, Luca Bertamini, Rahul Banerjee, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 7, 2012
Evaluation of the pharmacokinetics, preclinical, and clinical efficacy of lenalidomide for the treatment of multiple myelomaSara Bringhen, Francesca Gay, Chiara Pautasso, et al.
Expert Opinion on Biological Therapy|November 6, 2018
CD38 as an immunotherapeutic target in multiple myelomaFrancesca Bonello, Mattia D'Agostino, Maria Moscvin, et al.
Annals of the New York Academy of Sciences|October 8, 2008
Update on recent developments for patients with newly diagnosed multiple myelomaAntonio Palumbo, Valeria Magarotto, Francesca Gay, et al.
Current Medicinal Chemistry|May 15, 2018
Clinical and Pharmacologic Features of Monoclonal Antibodies and Checkpoint Blockade Therapy in Multiple MyelomaMattia D'Agostino, Giulia Gazzera, Giusy Cetani, et al.
Blood Reviews|April 17, 2021
Improving outcomes for patients with relapsed multiple myeloma: Challenges and considerations of current and emerging treatment optionsKarthik Ramasamy, Francesca Gay, Katja Weisel, et al.
Frontiers in Oncology|June 26, 2026
Current positioning and future development of belantamab mafodotin and other antibody-drug conjugates to treat multiple myelomaGiuseppe Bertuglia, Alessandro Di Nicola, Francesca Gay, et al.
Pageof 18

Showing results (21-30 of 174) with videos related to

Sort By:
Pageof 18
Cancers|December 19, 2019
Pursuing a Curative Approach in Multiple Myeloma: A Review of New Therapeutic StrategiesMattia D'Agostino, Luca Bertamini, Stefania Oliva, et al.
Oncotarget|September 27, 2017
Emerging drugs and combinations to treat multiple myelomaAlessandra Larocca, Roberto Mina, Francesca Gay, et al.
Expert Opinion on Investigational Drugs|June 7, 2014
Current Phase II investigational proteasome inhibitors for the treatment of multiple myelomaSara Bringhen, Francesca Gay, Francesca Donato, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 19, 2021
When and How to Treat Relapsed Multiple MyelomaNitya Nathwani, Luca Bertamini, Rahul Banerjee, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 7, 2012
Evaluation of the pharmacokinetics, preclinical, and clinical efficacy of lenalidomide for the treatment of multiple myelomaSara Bringhen, Francesca Gay, Chiara Pautasso, et al.
Expert Opinion on Biological Therapy|November 6, 2018
CD38 as an immunotherapeutic target in multiple myelomaFrancesca Bonello, Mattia D'Agostino, Maria Moscvin, et al.
Annals of the New York Academy of Sciences|October 8, 2008
Update on recent developments for patients with newly diagnosed multiple myelomaAntonio Palumbo, Valeria Magarotto, Francesca Gay, et al.
Current Medicinal Chemistry|May 15, 2018
Clinical and Pharmacologic Features of Monoclonal Antibodies and Checkpoint Blockade Therapy in Multiple MyelomaMattia D'Agostino, Giulia Gazzera, Giusy Cetani, et al.
Blood Reviews|April 17, 2021
Improving outcomes for patients with relapsed multiple myeloma: Challenges and considerations of current and emerging treatment optionsKarthik Ramasamy, Francesca Gay, Katja Weisel, et al.
Frontiers in Oncology|June 26, 2026
Current positioning and future development of belantamab mafodotin and other antibody-drug conjugates to treat multiple myelomaGiuseppe Bertuglia, Alessandro Di Nicola, Francesca Gay, et al.
Pageof 18